Table I.
Clinical characteristics of patients.
| Characteristic | SQCC | AC | P-value |
|---|---|---|---|
| Patients, n | 39 | 29 | |
| Jewish decent, n (%) | 35 (89.7) | 21 (72.4) | 0.11 |
| BMI, n (%) | 0.09 | ||
| ≤25 kg/m2 | 10 (62.5) | 6 (30.0) | |
| >25 kg/m2 | 6 (37.5) | 14 (70.0) | |
| BMIa | 26.05±6.3 (23.5) | 30.31±6.1 (32.0) | 0.05 |
| Age at diagnosis, yearsa | 54.4±13.36 (52.5) | 54.34±13.07 (54.0) | 0.98 |
| Histological grade, n (%) | |||
| 1 | 0 (0.0) | 9 (32.0) | 0.006 |
| 2 | 13 (43.0) | 11 (39.0) | 0.79 |
| 3 | 17 (57.0) | 8 (29.0) | 0.037 |
| FIGO stage, n (%) | |||
| I | 12 (31.0) | 12 (43.0) | 0.37 |
| II | 24 (62.0) | 11 (39.0) | 0.09 |
| III | 3 (8.0) | 4 (14.0) | 0.42 |
| IV | 0 (0.0) | 1 (4.0) | 0.15 |
| Treatment, n | |||
| Brachytherapy | 0 | 1 | 0.15 |
| Chemoradiotherapy (EBRT + brachytherapy) | 38 | 23 | 0.014 |
| EBRT + brachytherapy only | 1 | 5 | 0.09 |
a
Data are presented as the mean ± standard deviation. SQCC, squamous cell carcinoma; AC, adenocarcinoma; BMI, body mass index; FIGO, International Federation of Gynecology and Obstetrics; EBRT, external beam radiotherapy.